Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 19, 2015

View Archived Issues

Ablynx achieves preclinical PoC with Nanobody construct in Merck & Co. collaboration

Autotelic acquires rights to trabedersen from Isarna

RXi Pharmaceuticals reports interim data from phase IIa study of RXI-109

New company Decibel Therapeutics launched to address hearing loss

Novartis introduces JAK/TYK2 inhibitors

Actelion presents prostaglandin D2 receptor 2 antagonists

Rock Creek completes phase I trial of oral formulations of anatabine citrate

Novo Nordisk licenses use of Emisphere's Eligen technology for oral drug development

Sanofi Pasteur and IDRI create Global Health Vaccine Center of Innovation

Integral Molecular's Ebola antibody research supported by new NIAID award

Johnson & Johnson updates progress of third quarter 2015

Studies in vivo support clinical development of novel anti-miR-103/107 candidate RG-125

AbbVie's ABT-555 enters clinical evaluation for multiple sclerosis

Galapagos advances triple combination therapy in cystic fibrosis under AbbVie collaboration

FDA places partial clinical hold on beloranib

FDA approves Praxbind as dabigatran reversal agent

Genentech presents results from clinical trials of its anti-influenza antibody MHAA-4549A

Orion patents TRPA1 antagonists

Zheijiang University and Shanghai Institute of Materia Medica disclose PKB inhibitors

Merck KGaA and Cancer Research Technology divulge Wnt signaling inhibitors

Shionogi introduces anti-HIV agents

Lexicon describes orally active small-molecule inhibitors of NOTUM

New molecular probe [18F]5-FPN could be useful for melanoma diagnosis and staging

Phase I results for SUVN-G3031, a candidate to treat Alzheimer's disease

FDA requests additional data for lifitegrast NDA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...